9 March 2023 - Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs/
A new Amgen lung cancer treatment, Lumykras, carried a hefty price tag when it came out in 2021; $17,900 per patient monthly.
Read Wall Street Journal article (subscription required)